LATEST
GTCR agreed to acquire CCC Intelligent SolutionsnewEQT agreed to acquire StockbridgenewProofpoint agreed to acquire VaronisnewPyrophyte Acquisition . II / SakuuMotown Acquisition agreed to acquire Penske Automotive GroupVivos Therapeutics / SOD SciencesAtlasClear Holdings agreed to acquire Ark Financial ServicesLaboratory of America Holdings / BioReference HealthMubadala Capital acquired Clear Channel OutdoorIthaca Holdings agreed to acquire BumblePenta Fine Ingredients acquired SynerzineHexagon agreed to acquire Rocscience
Open App
Agreement signedPublished 26 May 2026

Apotex Inc. /
Cumberland Pharmaceuticals Inc.

Cumberland agrees to sell its FDA-approved product assets to Apotex

Buy side: Apotex Inc.
Buy sideApotex Inc.
Target: Cumberland Pharmaceuticals Inc.
TargetCumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Inc. · 26 May 2026Source
See the source
Follow Apotex Inc. Follow Cumberland Pharmaceuticals Inc.
Buy side: Apotex Inc.
Buy sideApotex Inc.
Target: Cumberland Pharmaceuticals Inc.
TargetCumberland Pharmaceuticals Inc.
01 / BuyerApotex Inc.
02 / TargetCumberland Pharmaceuticals Inc.
Source for the buyer and target: Cumberland Pharmaceuticals Inc.

For the buyer and target.

“The following chronology summarizes the material events that led to the execution of the Asset Purchase Agreement by and among Cumberland Pharmaceuticals Inc., a Tennessee corporation (“ Cumberland ”), Nuvo Pharmaceuticals (Ireland) DAC, an Ireland designated activity company, and Apotex Inc., as Buyer Guarantor (collectively with Nuvo Pharmaceuticals (Ireland) DAC, “ Apotex ”).”

Published 26 May 2026

Open the source
01

What happened

Cumberland Pharmaceuticals Inc. has agreed to sell assets tied to its FDA-approved products to Apotex for $100 million in cash payable at closing. The sale is subject to conditions, including approval by Cumberland's shareholders. [01]

Cumberland will keep its ifetroban product candidates and its majority-owned subsidiary Cumberland Emerging Technologies, which it intends to keep developing after the transaction. [01]

02

The source

Everything on this page comes from the source below, quoted word for word.

01
Source · Cumberland Pharmaceuticals Inc.

Cumberland agrees to sell its FDA-approved product assets to Apotex

This document is the source for the companies, stage, figure and people on this page.

Open the source
03

Timeline

Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by Cumberland Pharmaceuticals Inc.

    The source this page is built from.

    Open the source

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Get ProAlready a member? Sign in

Pro is open to everyone.

04

Deal Web

Every firm and person on this deal, and how they connect. Open any name to see their other deals.

Deal Web · 2 firms · 0 peopleHover a name to see how it connects
This dealApotex Inc. / Cumberland Pharmaceuticals Inc.Agreement signed · Published 26 May 2026
BuyerApotex Inc.TargetCumberland Pharmaceuticals Inc.
This dealApotex Inc. / Cumberland Pharmaceuticals Inc.

Agreement signed · Apotex Inc. / Cumberland Pharmaceuticals Inc. deal (Agreement signed, published 26 May 2026).

Published 26 May 2026
Timeline
  1. Published by Cumberland Pharmaceuticals Inc.
Hover or tap a name to see how it connects, and when
Deal Web as a list